Paul Hud­son is more con­fi­dent in Sanofi's abil­i­ty to pro­duce a Covid-19 vac­cine — re­port

Sanofi CEO Paul Hud­son ex­pressed re­newed con­fi­dence Fri­day re­gard­ing its com­pa­ny’s Covid-19 vac­cine can­di­date be­ing de­vel­oped with GSK.

As the can­di­date is set to start clin­i­cal tri­als some­time next month, Hud­son told Reuters that Sanofi has seen pos­i­tive da­ta so far this sum­mer. That gus­to builds up­on com­ments he made in June about the high­er like­li­hood Sanofi pro­duces a vac­cine with greater than 70% ef­fi­ca­cy com­pared to ri­vals.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER